Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

November 1, 1995; Volume 155,Issue 9

CUTTING EDGE

  • You have accessRestricted access
    A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
    W L Fodor, S A Rollins, E R Guilmette, E Setter and S P Squinto
    J Immunol November 1, 1995, 155 (9) 4135-4138;
  • You have accessRestricted access
    Inhibition of gamma delta T cell recognition by receptors for MHC class I molecules.
    H Nakajima, H Tomiyama and M Takiguchi
    J Immunol November 1, 1995, 155 (9) 4139-4142;
  • You have accessRestricted access
    The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
    S Rajagopalan, C C Winter, N Wagtmann and E O Long
    J Immunol November 1, 1995, 155 (9) 4143-4146;

ARTICLES

  • You have accessRestricted access
    Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen.
    M T Abreu-Martin, A Vidrich, D H Lynch and S R Targan
    J Immunol November 1, 1995, 155 (9) 4147-4154;
  • You have accessRestricted access
    Fibroblasts support outgrowth of splenocytes simultaneously expressing B lymphocyte and macrophage characteristics.
    M A Borrello and R P Phipps
    J Immunol November 1, 1995, 155 (9) 4155-4161;
  • You have accessRestricted access
    IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    J M Carballido, D Schols, R Namikawa, S Zurawski, G Zurawski, M G Roncarolo and J E de Vries
    J Immunol November 1, 1995, 155 (9) 4162-4170;
  • You have accessRestricted access
    Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition.
    J A Chies, G Marodon, A M Joret, A Regnault, M P Lembezat, B Rocha and A A Freitas
    J Immunol November 1, 1995, 155 (9) 4171-4178;
  • You have accessRestricted access
    A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Y L Colson, S M Wren, M J Schuchert, K D Patrene, P C Johnson, S S Boggs and S T Ildstad
    J Immunol November 1, 1995, 155 (9) 4179-4188;
  • You have accessRestricted access
    Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    C A Ellison, G C MacDonald, E S Rector and J G Gartner
    J Immunol November 1, 1995, 155 (9) 4189-4198;
  • You have accessRestricted access
    Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    S Fasler, G Aversa, A Terr, K Thestrup-Pedersen, J E de Vries and H Yssel
    J Immunol November 1, 1995, 155 (9) 4199-4206;
  • You have accessRestricted access
    Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    S Grabbe, K Steinbrink, M Steinert, T A Luger and T Schwarz
    J Immunol November 1, 1995, 155 (9) 4207-4217;
  • You have accessRestricted access
    Identification of a candidate CD5 homologue in the amphibian Xenopus laevis.
    J B Jürgens, L A Gartland, L Du Pasquier, J D Horton, T W Göbel and M D Cooper
    J Immunol November 1, 1995, 155 (9) 4218-4223;
  • You have accessRestricted access
    Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A.
    T Lin, G Matsuzaki, M Umesue, K Omoto, H Yoshida, M Harada, C Singaram, K Hiromatsu and K Nomoto
    J Immunol November 1, 1995, 155 (9) 4224-4230;
  • You have accessRestricted access
    Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo.
    Y Nakata, K Matsuda, A Uzawa, M Nomura, M Akashi and G Suzuki
    J Immunol November 1, 1995, 155 (9) 4231-4235;
  • You have accessRestricted access
    Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.
    M W Olszowy, P L Leuchtmann, A Veillette and A S Shaw
    J Immunol November 1, 1995, 155 (9) 4236-4240;
  • You have accessRestricted access
    Functional expression of CD40 antigen on human epidermal Langerhans cells.
    J Péguet-Navarro, C Dalbiez-Gauthier, F M Rattis, C Van Kooten, J Banchereau and D Schmitt
    J Immunol November 1, 1995, 155 (9) 4241-4247;
  • You have accessRestricted access
    IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny.
    J Punnonen, B G Cocks and J E de Vries
    J Immunol November 1, 1995, 155 (9) 4248-4254;
  • You have accessRestricted access
    Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking.
    W Song, H Cho, P Cheng and S K Pierce
    J Immunol November 1, 1995, 155 (9) 4255-4263;
  • You have accessRestricted access
    Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
    D Barchan, M Balass, M C Souroujon, E Katchalski-Katzir and S Fuchs
    J Immunol November 1, 1995, 155 (9) 4264-4269;
  • You have accessRestricted access
    Differential transcription efficiency of two Ig VH promoters in vitro.
    K L Buchanan, S I Hodgetts, J Byrnes and C F Webb
    J Immunol November 1, 1995, 155 (9) 4270-4277;
  • You have accessRestricted access
    Structure and expression of a divergent canine class I gene.
    R C Burnett and D E Geraghty
    J Immunol November 1, 1995, 155 (9) 4278-4285;
  • You have accessRestricted access
    Cloning and characterization of a mouse IL-12 receptor-beta component.
    A O Chua, V L Wilkinson, D H Presky and U Gubler
    J Immunol November 1, 1995, 155 (9) 4286-4294;
  • You have accessRestricted access
    Molecular analysis of a heteroclitic T cell response to the immunodominant epitope of sperm whale myoglobin. Implications for peptide partial agonists.
    R D England, M C Kullberg, J L Cornette and J A Berzofsky
    J Immunol November 1, 1995, 155 (9) 4295-4306;
  • You have accessRestricted access
    Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
    A Kondo, J Sidney, S Southwood, M F del Guercio, E Appella, H Sakamoto, E Celis, H M Grey, R W Chesnut, R T Kubo and A Sette
    J Immunol November 1, 1995, 155 (9) 4307-4312;
  • You have accessRestricted access
    Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    C S Moreno, P Emery, J E West, B Durand, W Reith, B Mach and J M Boss
    J Immunol November 1, 1995, 155 (9) 4313-4321;
  • You have accessRestricted access
    Influence of coding-end sequence on coding-end processing in V(D)J recombination.
    B Nadel and A J Feeney
    J Immunol November 1, 1995, 155 (9) 4322-4329;
  • You have accessRestricted access
    Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3).
    S Nagulapalli, J M Pongubala and M L Atchison
    J Immunol November 1, 1995, 155 (9) 4330-4338;
  • You have accessRestricted access
    Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.
    N Shastri, T Serwold and F Gonzalez
    J Immunol November 1, 1995, 155 (9) 4339-4346;
  • You have accessRestricted access
    IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    C A Hunter, R Chizzonite and J S Remington
    J Immunol November 1, 1995, 155 (9) 4347-4354;
  • You have accessRestricted access
    Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis.
    S A Safley, P E Jensen, P A Reay and H K Ziegler
    J Immunol November 1, 1995, 155 (9) 4355-4366;
  • You have accessRestricted access
    Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice.
    J Seebach, D Bartholdi, K Frei, K S Spanaus, E Ferrero, U Widmer, S Isenmann, R M Strieter, M Schwab, H Pfister and A Fontana
    J Immunol November 1, 1995, 155 (9) 4367-4375;
  • You have accessRestricted access
    Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
    G T Spear, N S Lurain, C J Parker, M Ghassemi, G H Payne and M Saifuddin
    J Immunol November 1, 1995, 155 (9) 4376-4381;
  • You have accessRestricted access
    Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.
    C Y Yim, J R McGregor, O D Kwon, N R Bastian, M Rees, M Mori, J B Hibbs Jr and W E Samlowski
    J Immunol November 1, 1995, 155 (9) 4382-4390;
  • You have accessRestricted access
    Macrophage activation by culture in an anoxic environment.
    J E Albina, W L Henry Jr, B Mastrofrancesco, B A Martin and J S Reichner
    J Immunol November 1, 1995, 155 (9) 4391-4396;
  • You have accessRestricted access
    Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells.
    O A Batuman, A Ferrero, C Cupp, S A Jimenez and K Khalili
    J Immunol November 1, 1995, 155 (9) 4397-4405;
  • You have accessRestricted access
    Proteinases of rat mast cells. Peritoneal but not intestinal mucosal mast cells express mast cell proteinase 5 and carboxypeptidase A.
    A D Befus, B Chin, J Pick, S Evans, S Osborn and J Forstrom
    J Immunol November 1, 1995, 155 (9) 4406-4411;
  • You have accessRestricted access
    Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
    N Berkman, M John, G Roesems, P J Jose, P J Barnes and K F Chung
    J Immunol November 1, 1995, 155 (9) 4412-4418;
  • You have accessRestricted access
    IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
    M Burg, U Martin, C Rheinheimer, J Köhl, W Bautsch, E C Böttger and A Klos
    J Immunol November 1, 1995, 155 (9) 4419-4426;
  • You have accessRestricted access
    Fc gamma II receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ channels which are distinct from those associated with Ca2+ store depletion.
    K Kuroda, Y Ozaki, R Qi, N Asazuma, Y Yatomi, K Satoh, S Nomura, M Suzuki and S Kume
    J Immunol November 1, 1995, 155 (9) 4427-4436;
  • You have accessRestricted access
    Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2.
    S J Mnich, A W Veenhuizen, J B Monahan, K C Sheehan, K R Lynch, P C Isakson and J P Portanova
    J Immunol November 1, 1995, 155 (9) 4437-4444;
  • You have accessRestricted access
    IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2.
    M Murakami, C O Bingham 3rd, R Matsumoto, K F Austen and J P Arm
    J Immunol November 1, 1995, 155 (9) 4445-4453;
  • You have accessRestricted access
    Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor.
    K Pazdrak, L Justement and R Alam
    J Immunol November 1, 1995, 155 (9) 4454-4458;
  • You have accessRestricted access
    Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
    D V Tambourgi, F C Magnoli, V R Von Eickstedt, Z C Benedetti, V L Petricevich and W D da Silva
    J Immunol November 1, 1995, 155 (9) 4459-4466;
  • You have accessRestricted access
    The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta.
    J M Watson, A K Lofquist, C A Rinehart, J C Olsen, S S Makarov, D G Kaufman and J S Haskill
    J Immunol November 1, 1995, 155 (9) 4467-4475;
  • You have accessRestricted access
    Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.
    N Y Yount, M S Wang, J Yuan, N Banaiee, A J Ouellette and M E Selsted
    J Immunol November 1, 1995, 155 (9) 4476-4484;
  • You have accessRestricted access
    Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    D C Linehan, P S Goedegebuure, G E Peoples, S O Rogers and T J Eberlein
    J Immunol November 1, 1995, 155 (9) 4486-4491;
  • You have accessRestricted access
    Ultraviolet B radiation up-regulates the expression of IL-15 in human skin.
    M Mohamadzadeh, A Takashima, I Dougherty, J Knop, P R Bergstresser and P D Cruz Jr
    J Immunol November 1, 1995, 155 (9) 4492-4496;
  • You have accessRestricted access
    Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.
    L C Pullen, S H Park, S D Miller, M C Dal Canto and B S Kim
    J Immunol November 1, 1995, 155 (9) 4497-4503;
  • You have accessRestricted access
    Vaccination with a recombinant V alpha domain of a TCR prevents the development of collagen-induced arthritis.
    E F Rosloniec, D D Brand, K B Whittington, J M Stuart, M Ciubotaru and E S Ward
    J Immunol November 1, 1995, 155 (9) 4504-4511;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 155, Issue 9
1 Nov 1995
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606